Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 11.00
-0.05 (-0.45%)
At close: Feb 11, 2026
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 990 million as of February 11, 2026. Its market cap has decreased by -31.46% in one year.
Market Cap
990.00M
Enterprise Value
1.13B
Revenue
371.86M
Ranking
n/a
PE Ratio
43.00
Stock Price
11.00
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 990.00M, a decrease of -75.84%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 990.00M | -1.35% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.30B |
| GeneReach Biotechnology | 1.20B |
| Lukas Biomedical | 1.19B |
| Holy Stone Healthcare | 1.13B |
| Neith | 1.08B |
| Level Biotechnology | 1.07B |
| TCI GENE | 1.01B |
| Eusol Biotech | 985.03M |